A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.

[1]  L. Agertoft,et al.  Dose titration of nebulized budesonide in young children , 1997, Pediatric pulmonology.

[2]  R. Sorva,et al.  Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1). , 1996, The European respiratory journal.

[3]  B. Lipworth,et al.  Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. , 1996, Thorax.

[4]  A. Ullman,et al.  Assessment of the relative systemic potency of inhaled fluticasone and budesonide. , 1996, The European respiratory journal.

[5]  B. Lipworth,et al.  Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. , 1996, Thorax.

[6]  S. Pedersen.  Inhalers and nebulizers: which to choose and why. , 1996, Respiratory medicine.

[7]  E. Bateman,et al.  High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. , 1995, The European respiratory journal.

[8]  S. Pedersen,et al.  Budesonide treatment of moderate and severe asthma in children: a dose-response study. , 1995, The Journal of allergy and clinical immunology.

[9]  A. Gulsvik,et al.  High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. , 1994, The European respiratory journal.

[10]  A. Grahnén,et al.  An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. , 1994, British journal of clinical pharmacology.

[11]  B. Lipworth,et al.  A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects. , 1994, British journal of clinical pharmacology.

[12]  R. Dockhorn,et al.  Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. , 1994, The Journal of allergy and clinical immunology.

[13]  S. Pedersen,et al.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. , 1994, Respiratory medicine.

[14]  R. Dahl,et al.  A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma , 1993 .

[15]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[16]  S. Pedersen,et al.  The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. , 1993, British journal of clinical pharmacology.

[17]  L. Fabbri,et al.  Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. , 1993, Thorax.

[18]  S. Pedersen,et al.  Importance of the inhalation device on the effect of budesonide. , 1993, Archives of disease in childhood.

[19]  B. Niggemann,et al.  Nebennierenrindenfunktion bei Kindern mit Asthma bronchiale unter Therapie mit Fluticason , 1993 .

[20]  G. Guyatt,et al.  A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.